Cosmos Health Inc.(COSM)Earnings, Financials & Key Ratios
COSM•NASDAQ
$0.35
$11M mkt cap·Price updated May 6, 2026
AboutCosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.Show more
- Revenue$54M+2.0%
- EBITDA-$14M+32.6%
- Net Income-$16M+12.7%
- EPS (Diluted)-1.17+45.6%
- Gross Margin7.92%-2.8%
- EBITDA Margin-26.27%+33.9%
- Operating Margin-28.56%+30.2%
- Net Margin-29.73%+14.4%
- ROE-53.43%-9.1%
- ROIC-28.9%+33.3%
- Debt/Equity0.48+39.8%
- Interest Coverage-15.36+39.1%
COSM Key Insights
Cosmos Health Inc. (COSM) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Trading at only 0.3x book value
- ✓Efficient asset utilization: 1.0x turnover
✗Weaknesses
- ✗Weak Piotroski F-Score: 3/9
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 12 (bottom 12%)
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Shares diluted 60.0% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
COSM Price & Volume
Cosmos Health Inc. (COSM) stock price & volume — 10-year historical chart
Loading chart...
COSM Growth Metrics
Cosmos Health Inc. (COSM) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years21.7%
5 Years6.53%
3 Years-1.09%
TTM6.69%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM9.07%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM49.2%
Return on Capital
10 Years-19.93%
5 Years-8.65%
3 Years-38.87%
Last Year-44.26%
COSM Peer Comparison
Cosmos Health Inc. (COSM) competitors in Consumer health and OTC self-care — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HROW | 1.5B | 40.27 | -287.64 | 36.41% | -1.89% | -10.07% | 4.84 | |
 NTRB | 48.33M | 3.97 | -1.54 | -4.83% | -404.08% | -118.3% | 0.03 | |
 XTLB | 357.58K | 3.25 | -0.34 | -227.72% | -25.53% | 0.03 | ||
 CODA | 134.35M | 11.92 | 32.22 | 30.75% | 14.78% | 7.17% | 0.01 | |
 PHVS | 1.96B | 30.11 | -10.35 | -53.18% | 0.00 | |||
 PAHC | 2.38B | 58.64 | 49.28 | 27.37% | 6.29% | 30.81% | 2.67 | |
 PRGO | 1.69B | 12.26 | -1.19 | -2.75% | -43.5% | -50.65% | 1.35 | |
 AMRX | 4.28B | 13.62 | 61.91 | 8.05% | 2.39% | 7.47% | 0.13 |
Compare COSM vs Peers
Cosmos Health Inc. (COSM) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
COSM Income Statement
Cosmos Health Inc. (COSM) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 6.76M | 30.01M | 37.08M | 39.68M | 55.41M | 56.24M | 50.35M | 53.38M | 54.43M | 59.79M |
| Revenue Growth % | 1165.53% | 344.28% | 23.56% | 6.99% | 39.65% | 1.5% | -10.48% | 6.02% | 1.97% | 6.69% |
| Cost of Goods Sold | 6.15M | 28.06M | 34.68M | 36.01M | 47.35M | 47.91M | 44.39M | 49.03M | 50.12M | 52.97M |
| COGS % of Revenue | 91.1% | 93.48% | 93.5% | 90.77% | 85.45% | 85.19% | 88.17% | 91.85% | 92.08% | - |
| Gross Profit | 601.04K▲ 0% | 1.96M▲ 225.5% | 2.41M▲ 23.1% | 3.66M▲ 52.0% | 8.06M▲ 120.1% | 8.33M▲ 3.4% | 5.96M▼ 28.5% | 4.35M▼ 27.0% | 4.31M▼ 0.9% | 6.82M▲ 0% |
| Gross Margin % | 8.9% | 6.52% | 6.5% | 9.23% | 14.55% | 14.81% | 11.83% | 8.15% | 7.92% | 11.41% |
| Gross Profit Growth % | 1126.79% | 225.48% | 23.12% | 52.05% | 120.09% | 3.35% | -28.49% | -26.98% | -0.88% | - |
| Operating Expenses | 803.55K | 6.83M | 3.64M | 3.92M | 5.35M | 12.86M | 13.43M | 26.18M | 19.86M | 21.08M |
| OpEx % of Revenue | 11.89% | 22.75% | 9.81% | 9.88% | 9.65% | 22.87% | 26.68% | 49.05% | 36.48% | - |
| Selling, General & Admin | 794.1K | 4.85M | 3.59M | 3.52M | 4.95M | 12.41M | 13.24M | 25.57M | 12.09M | 16.87M |
| SG&A % of Revenue | 11.76% | 16.17% | 9.69% | 8.88% | 8.93% | 22.07% | 26.3% | 47.9% | 22.21% | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 533.29K | 108.6K |
| R&D % of Revenue | - | - | - | - | - | - | - | - | 0.98% | - |
| Other Operating Expenses | 9.45K | 1.98M | 43.93K | 394.63K | 397.6K | 449.69K | 188.89K | 614.38K | 7.23M | 2.67M |
| Operating Income | -202.51K▲ 0% | -4.87M▼ 2306.0% | -1.23M▲ 74.8% | -255.81K▲ 79.2% | 2.71M▲ 1161.1% | -4.53M▼ 267.0% | -7.47M▼ 64.9% | -21.83M▼ 192.1% | -15.54M▲ 28.8% | -14.26M▲ 0% |
| Operating Margin % | -3% | -16.23% | -3.31% | -0.64% | 4.9% | -8.06% | -14.84% | -40.9% | -28.56% | -23.86% |
| Operating Income Growth % | 54.23% | -2306% | 74.79% | 79.18% | 1161.06% | -267.02% | -64.87% | -192.09% | 28.8% | - |
| EBITDA | -193.06K | -4.85M | -1.18M | 138.82K | 3.11M | -4.08M | -7.29M | -21.22M | -14.3M | -12.9M |
| EBITDA Margin % | -2.86% | -16.15% | -3.19% | 0.35% | 5.62% | -7.26% | -14.47% | -39.75% | -26.27% | -21.57% |
| EBITDA Growth % | 55.83% | -2410.33% | 75.56% | 111.72% | 2141.69% | -231.23% | -78.4% | -191.23% | 32.62% | 32.43% |
| D&A (Non-Cash Add-back) | 9.45K | 25.9K | 43.93K | 394.63K | 397.6K | 449.69K | 188.89K | 614.38K | 1.25M | 1.36M |
| EBIT | -394.22K | -4.57M | -2.24M | -1.38M | 3.99M | -4.27M | -9.09M | -17.68M | -15.17M | -16.28M |
| Net Interest Income | -206.01K | -1.64M | -6.81M | -1.73M | -2.73M | -3.53M | -3.73M | -203.62K | -605.87K | -1.33M |
| Interest Income | 0 | 0 | 0 | 0 | 65.86K | 46.32K | 236.35K | 662.86K | 406.45K | 395.23K |
| Interest Expense | 206.01K | 1.64M | 6.81M | 1.73M | 2.8M | 3.58M | 3.97M | 866.48K | 1.01M | 1.73M |
| Other Income/Expense | -397.73K | -1.33M | -7.81M | -2.86M | -1.52M | -3.31M | -5.58M | 3.29M | -638.19K | -4.28M |
| Pretax Income | -600.23K▲ 0% | -6.21M▼ 934.1% | -9.04M▼ 45.7% | -3.12M▲ 65.5% | 1.2M▲ 138.5% | -7.85M▼ 754.9% | -13.06M▼ 66.4% | -18.54M▼ 42.0% | -16.18M▲ 12.7% | -18.54M▲ 0% |
| Pretax Margin % | -8.89% | -20.68% | -24.39% | -7.85% | 2.16% | -13.95% | -25.93% | -34.74% | -29.73% | -31.01% |
| Income Tax | 769 | 2.8K | 17.33K | 182.81K | 377.54K | 114.01K | 775.05K | 0 | 0 | 0 |
| Effective Tax Rate % | -0.13% | -0.05% | -0.19% | -5.87% | 31.51% | -1.45% | -5.94% | 0% | 0% | 0% |
| Net Income | -601K▲ 0% | -6.21M▼ 933.2% | -9.06M▼ 45.9% | -3.3M▲ 63.6% | 820.79K▲ 124.9% | -7.96M▼ 1070.0% | -13.83M▼ 73.7% | -18.54M▼ 34.1% | -16.18M▲ 12.7% | -18.54M▲ 0% |
| Net Margin % | -8.9% | -20.69% | -24.43% | -8.31% | 1.48% | -14.16% | -27.47% | -34.74% | -29.73% | -31.01% |
| Net Income Growth % | 91.01% | -933.24% | -45.91% | 63.59% | 124.88% | -1070% | -73.71% | -34.07% | 12.73% | 9.07% |
| Net Income (Continuing) | -601K | -6.21M | -9.06M | -3.3M | 820.79K | -7.96M | -13.83M | -18.54M | -16.18M | -18.54M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.20▲ 0% | -12.25▼ 920.8% | -17.02▼ 38.9% | -6.21▲ 63.5% | 1.54▲ 124.8% | -23.74▼ 1641.6% | -33.16▼ 39.7% | -2.15▲ 93.5% | -1.17▲ 45.6% | -0.61▲ 0% |
| EPS Growth % | 90.98% | -920.83% | -38.94% | 63.51% | 124.8% | -1641.56% | -39.68% | 93.52% | 45.58% | 49.2% |
| EPS (Basic) | -1.25 | -12.25 | -17.02 | -6.21 | 1.55 | -23.74 | -33.16 | -2.15 | -1.17 | - |
| Diluted Shares Outstanding | 502.59K | 511.2K | 532.26K | 530.94K | 532.31K | 656.93K | 1.93M | 11.97M | 19.15M | 30.63M |
| Basic Shares Outstanding | 480.8K | 506.92K | 532.26K | 530.94K | 530.8K | 656.93K | 1.93M | 11.97M | 19.15M | 30.63M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
COSM Balance Sheet
Cosmos Health Inc. (COSM) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 2.64M | 9.51M | 18.35M | 21.18M | 40.77M | 39.83M | 56.04M | 36.61M | 25.46M | 38.1M |
| Cash & Short-Term Investments | 716.59K | 782.85K | 3.58M | 277.48K | 851.19K | 297.95K | 20.76M | 3.85M | 336.25K | 922.62K |
| Cash Only | 716.59K | 782.85K | 864.34K | 38.54K | 628.39K | 286.49K | 20.75M | 3.83M | 315.11K | 889.44K |
| Short-Term Investments | 0 | 0 | 2.72M | 238.94K | 222.79K | 11.47K | 14.88K | 20.07K | 21.15K | 33.18K |
| Accounts Receivable | 793.75K | 1.43M | 4.94M | 9.27M | 26.91M | 30.14M | 22.76M | 21.71M | 15.88M | 19.64M |
| Days Sales Outstanding | 42.89 | 17.35 | 48.65 | 85.26 | 177.27 | 195.59 | 165.02 | 148.47 | 106.5 | 108.3 |
| Inventory | 464.22K | 3.09M | 3.2M | 3.47M | 3.29M | 3.15M | 3.45M | 4.79M | 4.36M | 5.68M |
| Days Inventory Outstanding | 27.53 | 40.24 | 33.71 | 35.21 | 25.38 | 23.98 | 28.38 | 35.65 | 31.72 | 34.26 |
| Other Current Assets | 0 | 772.62K | 189.76K | 665.49K | 1.1M | -4.77K | 9.07M | 1.95M | 4.89M | 5.58M |
| Total Non-Current Assets | 481.92K | 1.17M | 2.35M | 2.7M | 3.07M | 9.6M | 11.67M | 29.41M | 28.85M | 31.39M |
| Property, Plant & Equipment | 52.72K | 114.57K | 1.43M | 1.73M | 1.76M | 2.93M | 2.93M | 11.62M | 10.4M | 11.32M |
| Fixed Asset Turnover | 128.15x | 261.97x | 26.01x | 22.87x | 31.53x | 19.17x | 17.18x | 4.60x | 5.23x | 4.99x |
| Goodwill | 0 | 0 | 49.7K | 49.7K | 49.7K | 49.7K | 49.7K | 49.7K | 49.7K | 0 |
| Intangible Assets | 0 | 41.99K | 247.07K | 213.98K | 180.81K | 436.07K | 657.22K | 7.63M | 7.71M | 7.96M |
| Long-Term Investments | 0 | 0 | 0 | 4.38K | 0 | 0 | 0 | 165.93K | 5.77M | 5.77M |
| Other Non-Current Assets | 429.2K | 1.01M | 624.48K | 698.06K | 905.32K | 5.33M | 8.03M | 9.94M | 4.92M | 35.42M |
| Total Assets | 3.12M▲ 0% | 10.68M▲ 242.3% | 20.69M▲ 93.9% | 23.88M▲ 15.4% | 43.84M▲ 83.6% | 49.43M▲ 12.7% | 68.04M▲ 37.6% | 66.01M▼ 3.0% | 54.31M▼ 17.7% | 69.49M▲ 0% |
| Asset Turnover | 2.17x | 2.81x | 1.79x | 1.66x | 1.26x | 1.14x | 0.74x | 0.81x | 1.00x | 0.98x |
| Asset Growth % | 374.21% | 242.33% | 93.85% | 15.39% | 83.61% | 12.74% | 37.65% | -2.97% | -17.73% | -16.63% |
| Total Current Liabilities | 4.87M | 13.7M | 22.27M | 28.24M | 34.29M | 29.93M | 21.75M | 24.32M | 25.76M | 38.53M |
| Accounts Payable | 591.69K | 2.17M | 5.93M | 8M | 11.97M | 12.13M | 10.26M | 11.91M | 11.16M | 14.68M |
| Days Payables Outstanding | 35.09 | 28.18 | 62.46 | 81.1 | 92.31 | 92.39 | 84.36 | 88.68 | 81.26 | 86.97 |
| Short-Term Debt | 3.2M | 10.18M | 15.02M | 18.65M | 19.7M | 13.34M | 8.04M | 8.23M | 9.55M | 14.7M |
| Deferred Revenue (Current) | 0 | 0 | 1.07M | 247.32K | 22.34K | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 111.21K | 165.27K | 799.73K | 1.3M | 2.7M | 3.47M | 3.35M | 8.4M |
| Current Ratio | 0.54x | 0.69x | 0.82x | 0.75x | 1.19x | 1.33x | 2.58x | 1.51x | 0.99x | 0.99x |
| Quick Ratio | 0.45x | 0.47x | 0.68x | 0.63x | 1.09x | 1.23x | 2.42x | 1.31x | 0.82x | 0.82x |
| Cash Conversion Cycle | 35.33 | 29.42 | 19.91 | 39.37 | 110.34 | 127.18 | 109.03 | 95.45 | 56.96 | 55.58 |
| Total Non-Current Liabilities | 0 | 0 | 1.74M | 2.1M | 13.72M | 15.12M | 6.63M | 5.65M | 4.02M | 7.82M |
| Long-Term Debt | 0 | 0 | 1.55M | 0 | 11.27M | 12.72M | 2.86M | 3.04M | 1.56M | 5.71M |
| Capital Lease Obligations | 0 | 0 | 0 | 435.55K | 778.71K | 844.42K | 860.1K | 850.13K | 501.8K | 1.85M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 183.58K | 1.66M | 1.66M | 1.55M | 2.91M | 1.76M | 1.96M | 7.67M |
| Total Liabilities | 4.87M | 13.7M | 24.01M | 30.34M | 48.01M | 45.05M | 28.38M | 29.97M | 29.78M | 46.36M |
| Total Debt | 3.2M | 10.18M | 16.58M | 19.29M | 32.04M | 27.12M | 12.03M | 12.42M | 11.82M | 21.07M |
| Net Debt | 2.48M | 9.4M | 15.71M | 19.25M | 31.41M | 26.84M | -8.72M | 8.59M | 11.51M | 20.18M |
| Debt / Equity | - | - | - | - | - | 6.19x | 0.30x | 0.34x | 0.48x | 0.48x |
| Debt / EBITDA | - | - | - | 138.93x | 10.30x | - | - | - | - | -1.63x |
| Net Debt / EBITDA | - | - | - | 138.65x | 10.10x | - | - | - | - | -1.56x |
| Interest Coverage | -0.98x | -2.98x | -0.18x | -0.15x | 0.97x | -1.27x | -1.88x | -25.20x | -15.36x | -9.42x |
| Total Equity | -1.75M▲ 0% | -3.03M▼ 72.7% | -3.32M▼ 9.6% | -6.46M▼ 94.8% | -4.16M▲ 35.6% | 4.38M▲ 205.2% | 39.66M▲ 805.5% | 36.04M▼ 9.1% | 24.53M▼ 31.9% | 23.13M▲ 0% |
| Equity Growth % | -40.47% | -72.74% | -9.56% | -94.75% | 35.6% | 205.25% | 805.52% | -9.11% | -31.93% | -109% |
| Book Value per Share | -3.49 | -5.92 | -6.23 | -12.17 | -7.82 | 6.67 | 20.57 | 3.01 | 1.28 | 0.76 |
| Total Shareholders' Equity | -1.75M | -3.03M | -3.32M | -6.46M | -4.16M | 4.38M | 39.66M | 36.04M | 24.53M | 23.13M |
| Common Stock | 125.87K | 12.82K | 13.88K | 13.22K | 13.48K | 702 | 10.61K | 15.98K | 23.69K | 31.96K |
| Retained Earnings | -1M | -7.21M | -16.27M | -19.57M | -18.75M | -34.35M | -66.23M | -91.64M | -114.02M | -123.02M |
| Treasury Stock | 0 | -95.88K | -225.49K | -411.85K | -611.85K | -816.71K | -816.71K | -917.16K | -917.16K | -917.16K |
| Accumulated OCI | -1.05M | -1.39M | 32.83K | -16.34K | 854.9K | -151.62K | -1.13M | -419.84K | -2.13M | 714.05K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
COSM Cash Flow Statement
Cosmos Health Inc. (COSM) cash flow — operating, investing & free cash flow history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -2.13M | -8.76M | -1.56M | -4.79M | -11.5M | -7.1M | -14.87M | -15.64M | -7.72M | -7.72M |
| Operating CF Margin % | -31.47% | -29.19% | -4.19% | -12.07% | -20.76% | -12.62% | -29.54% | -29.29% | -14.18% | - |
| Operating CF Growth % | -327.71% | -312.03% | 82.25% | -207.9% | -140.18% | 38.29% | -109.53% | -5.15% | 50.65% | -1045.02% |
| Net Income | -601K | -6.21M | -9.06M | -3.3M | 820.79K | -7.96M | -13.83M | -18.54M | -16.18M | -18.54M |
| Depreciation & Amortization | 9.45K | 25.9K | 43.93K | 394.63K | 397.6K | 449.69K | 188.89K | 614.38K | 1.25M | 1.36M |
| Stock-Based Compensation | 16.64K | 740.59K | 242K | 0 | 0 | 5.9M | 24.4K | 577.93K | 1.69M | 1.75M |
| Deferred Taxes | 0 | 0 | 0 | 0 | -178.43K | -714.11K | 780.1K | 656.98K | -11.84K | 10.64K |
| Other Non-Cash Items | 16.06K | 2.84M | 6.55M | 1.73M | -667.16K | 1.52M | 6.66M | 8.96M | 5.38M | 7.41M |
| Working Capital Changes | -1.57M | -6.15M | 667.35K | -3.61M | -11.87M | -6.3M | -8.69M | -7.9M | 159.68K | -1.19M |
| Change in Receivables | -565.31K | -706.3K | 465.45K | -4.32M | -15.72M | -8.46M | -7.46M | -4.03M | 1.23M | -3.84M |
| Change in Inventory | -272.35K | -2.62M | 1.43M | -271.45K | 393.15K | -89.58K | -485.47K | -890.9K | 146.45K | -535.07K |
| Change in Payables | 254.76K | 809.12K | -629.72K | 2.73M | 3.21M | 3.82M | 1.73M | 716.62K | 1.05M | 2.95M |
| Cash from Investing | -144.72K | -14.48K | -195.77K | 588.93K | -117.74K | -826.82K | -21.5K | -13.76M | -798.27K | -1.95M |
| Capital Expenditures | -12.82K | -55.34K | -503.36K | -672.79K | -117.74K | -581.4K | -74.21K | -2.98M | -418.07K | -119.94K |
| CapEx % of Revenue | 0.19% | 0.18% | 1.36% | 1.7% | 0.21% | 1.03% | 0.15% | 5.58% | 0.77% | - |
| Acquisitions | 0 | 40.86K | 307.59K | 0 | 0 | 0 | 0 | -5.23M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -131.9K | 0 | 0 | 0 | 0 | -245.42K | 55.34K | -5.55M | -380.19K | -830.58K |
| Cash from Financing | 2.74M | 9.29M | 1.99M | 3.59M | 12.46M | 7.27M | 35.05M | 12.69M | 5.05M | 12.49M |
| Debt Issued (Net) | 2.72M | 9.23M | 2.07M | 4.43M | 12.66M | 7.39M | -13.86M | -21.41K | 548.24K | 11.65M |
| Equity Issued (Net) | 0 | 57.32K | -80.05K | -845.25K | -200K | -126.86K | 1000K | 1000K | 649.04K | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.2M | 0 |
| Share Repurchases | 0 | -34.46K | -80.05K | -845.25K | -200K | -376.86K | 0 | -100.45K | 0 | 0 |
| Other Financing | 24.14K | 0 | 0 | 0 | 0 | 0 | 7.63M | 2.82M | 10.04M | -182.45K |
| Net Change in Cash | 518.54K▲ 0% | 66.26K▼ 87.2% | 81.49K▲ 23.0% | -825.81K▼ 1113.4% | 589.86K▲ 171.4% | -341.91K▼ 158.0% | 20.46M▲ 6085.0% | -16.92M▼ 182.7% | -3.52M▲ 79.2% | 1.32M▲ 0% |
| Free Cash Flow | -2.14M▲ 0% | -8.82M▼ 312.2% | -2.06M▲ 76.6% | -5.46M▼ 165.3% | -11.62M▼ 112.7% | -7.99M▲ 31.3% | -15.25M▼ 91.0% | -24.8M▼ 62.6% | -8.14M▲ 67.2% | -10.27M▲ 0% |
| FCF Margin % | -31.66% | -29.37% | -5.55% | -13.77% | -20.97% | -14.2% | -30.3% | -46.47% | -14.95% | -17.17% |
| FCF Growth % | -295.33% | -312.15% | 76.65% | -165.3% | -112.75% | 31.26% | -90.97% | -62.61% | 67.2% | -50.22% |
| FCF per Share | -4.26 | -17.24 | -3.87 | -10.29 | -21.83 | -12.16 | -7.91 | -2.07 | -0.42 | -0.42 |
| FCF Conversion (FCF/Net Income) | 3.54x | 1.41x | 0.17x | 1.45x | -14.01x | 0.89x | 1.08x | 0.84x | 0.48x | 0.55x |
| Interest Paid | 0 | 0 | 0 | 447.73K | 955.38K | 2.06M | 588.05K | 406.88K | 0 | 886.87K |
| Taxes Paid | 0 | 0 | 0 | 11.61K | 14.13K | 0 | 0 | 0 | 0 | 0 |
COSM Key Ratios
Cosmos Health Inc. (COSM) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | - | - | - | -7289.22% | -62.81% | -48.99% | -53.43% | -80.15% |
| Return on Invested Capital (ROIC) | -20.82% | -102.97% | -9.82% | -1.52% | 10.17% | -11.63% | -18.04% | -43.34% | -28.9% | -28.9% |
| Gross Margin | 8.9% | 6.52% | 6.5% | 9.23% | 14.55% | 14.81% | 11.83% | 8.15% | 7.92% | 11.41% |
| Net Margin | -8.9% | -20.69% | -24.43% | -8.31% | 1.48% | -14.16% | -27.47% | -34.74% | -29.73% | -31.01% |
| Debt / Equity | - | - | - | - | - | 6.19x | 0.30x | 0.34x | 0.48x | 0.48x |
| Interest Coverage | -0.98x | -2.98x | -0.18x | -0.15x | 0.97x | -1.27x | -1.88x | -25.20x | -15.36x | -9.42x |
| FCF Conversion | 3.54x | 1.41x | 0.17x | 1.45x | -14.01x | 0.89x | 1.08x | 0.84x | 0.48x | 0.55x |
| Revenue Growth | 1165.53% | 344.28% | 23.56% | 6.99% | 39.65% | 1.5% | -10.48% | 6.02% | 1.97% | 6.69% |
COSM Frequently Asked Questions
Cosmos Health Inc. (COSM) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Cosmos Health Inc. (COSM) reported $59.8M in revenue for fiscal year 2024.
Cosmos Health Inc. (COSM) grew revenue by 2.0% over the past year. Growth has been modest.
Cosmos Health Inc. (COSM) reported a net loss of $18.5M for fiscal year 2024.
Dividend & Returns
Yes, Cosmos Health Inc. (COSM) pays a dividend with a yield of 91.91%. This makes it attractive for income-focused investors.
Cosmos Health Inc. (COSM) has a return on equity (ROE) of -53.4%. Negative ROE indicates the company is unprofitable.
Cosmos Health Inc. (COSM) had negative free cash flow of $10.3M in fiscal year 2024, likely due to heavy capital investments.
Explore More COSM
Cosmos Health Inc. (COSM) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates